Treatment of Crohn's disease with colony-stimulating factors: An overview.

about

The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis.Efficacy of Intrauterine Injection of Granulocyte Colony Stimulating Factor (G-CSF) on Treatment of Unexplained Recurrent Miscarriage: A Pilot RCT Study.

P2860

Q37777393-CEC8C8A7-843E-4CAE-A1C9-DF7187A75A02 Q45924332-B3581D54-BE3A-4027-8766-DCCDA885C088

P2860

Treatment of Crohn's disease with colony-stimulating factors: An overview.

Item

http://www.wikidata.org/entity/Q43203199

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Treatment of Crohn's disease with colony-stimulating factors: An overview.

@en

Treatment of Crohn's disease with colony-stimulating factors: An overview.

@nl

type

Item

label

Treatment of Crohn's disease with colony-stimulating factors: An overview.

@en

Treatment of Crohn's disease with colony-stimulating factors: An overview.

@nl

prefLabel

Treatment of Crohn's disease with colony-stimulating factors: An overview.

@en

Treatment of Crohn's disease with colony-stimulating factors: An overview.

@nl

P1476

Treatment of Crohn's disease with colony-stimulating factors: An overview.

@en

P2093

Giammarco Mocci

http://www.w3.org/2001/XMLSchema#string

Luisa Guidi

http://www.w3.org/2001/XMLSchema#string

Manuela Marzo

http://www.w3.org/2001/XMLSchema#string

Sergio Rutella

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Genetics of inflammatory bowel disease: scientific and clinical implications

Sargramostim for active Crohn's disease

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.

Peptide growth factors in the intestine.

P304

927-934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S2756

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19209275

http://www.w3.org/2001/XMLSchema#string

P932

2621411

http://www.w3.org/2001/XMLSchema#string

Treatment of Crohn's disease with colony-stimulating factors: An overview.

about

P2860

P2860

Treatment of Crohn's disease with colony-stimulating factors: An overview.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932